Nano-sized drug delivery systems are an emerging field in biomedical sciences. Delivery systems in the nanometer range are very promising drug carriers due to their ability to overcome many limitations associated with conventional drug delivery systems including multi-drug resistance in cancer treatment. Advances in dry powder inhalers and the development of suitable carriers for nano-medical drug delivery systems enable the application of nano-medical treatment strategies to the pulmonary route of administration.